Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Validation of the Korean Version of the Walking Impairment Questionnaire in Patients With Peripheral Arterial Disease

This study has been completed.
Sponsor:
Collaborator:
Astellas Pharma Korea, Inc.
Information provided by (Responsible Party):
Seung-Kee Min, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01654471
First received: July 27, 2012
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)